GreenLight Biosciences Holdings (GRNA)
GreenLight Biosciences Holdings operates in the Biotechnology industry of the Healthcare sector, headquartered in Medford, MA, US. The stock last traded at $0.30, down 0.03% on the session, giving a market capitalisation of $45.4M. On trailing twelve-month figures it carries a trailing P/E of -0.24, a net margin of -2616.8%. Its beta of 1.44 implies it has historically moved more than the broad market.
GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings feature RNA-based innovations designed to protect honeybees and defend crops. Established in 2008, GreenLight Biosciences Holdings is based in Medford, Massachusetts.
GreenLight Biosciences Holdings is most often compared with the following Healthcare names: